Domov › Rak mehurja › Pennsylvania › Philadelphia
Klinične študije za Rak mehurja v Philadelphia, PA
21 študij za Rak mehurja išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Vključevanje udeležencevFaza 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi stran
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
Vključevanje udeležencev
- Abramson Cancer Center, Philadelphia
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Vključevanje udeležencevFaza 3
- Fox Chase Cancer Center, Philadelphia
- Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi stran
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Vključevanje udeležencevFaza 2
- MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi stran
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Vključevanje udeležencevFaza 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi stran
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Vključevanje udeležencev
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Vključevanje udeležencevFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Vključevanje udeležencevOpazovalna študija
- University of Pennsylvania, Philadelphia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Vključevanje udeležencevFaza 2
- University of Pennsylvania, Philadelphia
- Midlantic Urology (Solaris), Bala-Cynwyd · 5 mi stran
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Vključevanje udeležencevFaza 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi stran
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi stran
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Vključevanje udeležencevFaza 1/2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Vključevanje udeležencevFaza 2
- Thomas Jefferson University, Philadelphia
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Vključevanje udeležencevFaza 1
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Pennsylvania, Philadelphia
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Vključevanje udeležencev
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Philadelphia
Študije za Rak mehurja v drugih mestih
- New York City, NY35 študij
- Nashville, TN31 študij
- Houston, TX31 študij
- Dallas, TX27 študij
- Washington, DC26 študij
- Boston, MA26 študij
- Baltimore, MD24 študij
- Los Angeles, CA24 študij
- St. Louis, MO22 študij
- Seattle, WA21 študij
- Chicago, IL21 študij
- Edison, NJ21 študij
Druge študije v Philadelphia
- Rak (vse vrste)59 študij
- Rak dojke56 študij
- Nemalicelični pljučni rak51 študij
- Metastatski rak46 študij
- Rak prostate44 študij
- Kolorektalni rak44 študij
- Rak jajčnikov44 študij
- Rak pljuč36 študij
- Akutna mieločna levkemija34 študij
- Srčno popuščanje31 študij
- Rak endometrija28 študij
- Depresija26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.